Literature DB >> 1639508

Adoptively transferred anti-idiotype pulsed B cells mediate autoimmune myocarditis.

R E Paque1, R Miller.   

Abstract

Syngeneic mice receiving adoptively transferred enriched B cells or splenocytes pulsed in vitro with polyclonal anti-idiotypic antibodies (anti-Ids) against anti-CVB3 virus antibodies developed coxsackievirus B3 antigen-binding and virus-neutralizing antibodies during a 30-day period, in addition to overt expression of autoimmune myocarditis. Adoptive transfer of anti-Id pulsed T cells resulted in delayed appearance and transient expression of antiviral antibodies, and antiviral antibodies were marginal to absent in syngeneic animals receiving anti-Id pulsed macrophage populations. Proliferation analysis of recipient splenocytes indicated lack of proliferative capacity in response to monoclonal or polyclonal anti-Ids and only marginal proliferative capacity in response to coxsackievirus B3 virus antigen(s). In vitro assessment of delayed hypersensitivity in recipient animals demonstrated some specific immunity to anti-Ids in recipients receiving splenocytes or T cells. Anti-Ids expressing mimicry for heart-associated and/or viral antigen(s) interacting with B cells or other accessory cells suggest an autoantibody or anti-Id triggering of B-cell-mediated mechanisms involved in the development of myocarditis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1639508      PMCID: PMC257327          DOI: 10.1128/iai.60.8.3396-3404.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  Myosin: a link between streptococci and heart.

Authors:  K Krisher; M W Cunningham
Journal:  Science       Date:  1985-01-25       Impact factor: 47.728

2.  Anti-cardiolipin antibodies in infectious mononucleosis react with the membrane of activated lymphocytes.

Authors:  R Misra; P J Venables; C Plater-Zyberk; P F Watkins; R N Maini
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

3.  Autoantibodies directed against heart antigens and endocrine reactivity in patients with recent myocardial infarction.

Authors:  J Kuch
Journal:  Cardiovasc Res       Date:  1973-09       Impact factor: 10.787

Review 4.  Idiotypic vaccines and infectious diseases.

Authors:  J R Hiernaux
Journal:  Infect Immun       Date:  1988-06       Impact factor: 3.441

5.  Guillain-Barré syndrome associated with cytomegalovirus infection.

Authors:  I K Hart; P G Kennedy
Journal:  Q J Med       Date:  1988-05

6.  Heart-specific autoantibodies induced by Coxsackievirus B3: identification of heart autoantigens.

Authors:  F L Alvarez; N Neu; N R Rose; S W Craig; K W Beisel
Journal:  Clin Immunol Immunopathol       Date:  1987-04

7.  Autoantibodies specific for the cardiac myosin isoform are found in mice susceptible to Coxsackievirus B3-induced myocarditis.

Authors:  N Neu; K W Beisel; M D Traystman; N R Rose; S W Craig
Journal:  J Immunol       Date:  1987-04-15       Impact factor: 5.422

8.  Monoclonal anti-idiotypic antibodies regulate the expression of virus-induced murine myocarditis.

Authors:  R E Paque; R Miller
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

9.  Autoanti-idiotypes exhibit mimicry of myocyte antigens in virus-induced myocarditis.

Authors:  R E Paque; R Miller
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

10.  Molecular mimicry of a carbohydrate epitope on a major surface glycoprotein of Trypanosoma cruzi by using anti-idiotypic antibodies.

Authors:  D L Sacks; L V Kirchhoff; S Hieny; A Sher
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

View more
  2 in total

Review 1.  Unresolved issues in theories of autoimmune disease using myocarditis as a framework.

Authors:  Robert Root-Bernstein; DeLisa Fairweather
Journal:  J Theor Biol       Date:  2014-12-04       Impact factor: 2.691

Review 2.  Roles of Host Immunity in Viral Myocarditis and Dilated Cardiomyopathy.

Authors:  Lifang Zhao; Zhaoying Fu
Journal:  J Immunol Res       Date:  2018-05-07       Impact factor: 4.818

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.